Back to today’s briefing

Story perspectives

Revolutionary Gene Therapy Restores Hearing in 10 Kids

2/28/2025

24 3

Summary

Story summary

Regeneron's groundbreaking DB-OTO gene therapy is making waves in the fight against genetic deafness. In the CHORD trial, 10 out of 11 children with otoferlin-related hearing loss experienced remarkable improvements in their hearing. With its minimal side effects, this innovative treatment could transform lives and encourage genetic testing for hearing issues.

1 of 1

Story summary

Regeneron's groundbreaking DB-OTO gene therapy is making waves in the fight against genetic deafness. In the CHORD trial, 10 out of 11 children with otoferlin-related hearing loss experienced remarkable improvements in their hearing. With its minimal side effects, this innovative treatment could transform lives and encourage genetic testing for hearing issues.